Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs

Journal of Clinical Pharmacy and Therapeutics

Volumn 29, Issue 2, 2004, Pages 183-187

  Takada, M ^a   Fukumoto, K ^a   Shibakawa, M ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Aspirin; Buffered formulation; Enteric coated formulation; Gastrointestinal complications; Low dose aspirin therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT; CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NIZATIDINE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; ROXATIDINE; STOMACH SECRETION INHIBITOR;

ARTICLE; AUTOMATION; DATA BASE; ENTERIC COATED TABLET; GASTROINTESTINAL SYMPTOM; HUMAN; LOW DRUG DOSE; PRESCRIPTION;

ADMINISTRATION, ORAL; ASPIRIN; CARDIOVASCULAR DISEASES; DATABASES, FACTUAL; GASTROINTESTINAL HEMORRHAGE; HISTAMINE H2 ANTAGONISTS; HUMANS; JAPAN; PLATELET AGGREGATION INHIBITORS; PRESCRIPTIONS, DRUG; TABLETS, ENTERIC-COATED;

EID: 1842734425     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2004.00551.x     Document Type: Article

References (17)

1. Graham DY, Smith JL (1986) Aspirin and the stomach. Annals of Internal Medicine, 104, 390-398.
2. Ali M, McDonald JW, Thiessen JJ, Coates PE (1980) Plasma acetylsalicylate and salicylate and platelet cyclo-oxygenase activity following plain and enteric-coated aspirin. Stroke, 11, 9-13.
3. Wolfe MM, Lichtenstein DR, Singh G (1999) Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. New England Journal of Medicine, 340, 1888-1899.
4. Lanas AI (2001) Current approaches to reducing gastrointestinal toxicity of low-dose aspirin. American Journal of Medicine, 110, 70S-73S.
5. Lanas A, Bajador E, Serrano P et al. (2000) Nitrovasodilators, low-dose aspirin, other nonsteroidal anti-inflammatory drugs, and the risk of upper gastrointestinal bleeding. New England Journal of Medicine, 343, 834-839.
6. Lai KC, Lam SK, Chu KM et al. (2002) Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. New England Journal of Medicine, 346, 2033-2038.
7. Hoftiezer JW, Silvoso GR, Burks M, Ivey KJ (1980) Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet, 2, 609-612.
8. Lanza FL, Royer GL Jr, Nelson RS (1980) Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. New England Journal of Medicine, 303, 136-138.
9. Hawthorne AB, Mahida YR, Cole AT, Hawkey CJ (1991) Aspirin-induced gastric mucosa damage: prevention by enteric-coating and relation to prostaglandin synthesis. British Journal of Clinical Pharmacology, 32, 77-83.
10. Petroski D (1993) Endoscopic comparison of three aspirin preparations and placebo. Clinical Therapeutics, 15, 314-320.
11. Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S (1996) Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet, 348, 1413-1416.
12. de Abajo FJ, Garcia Rodriguez LA (2001) Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations. BMC Clinical Pharmacology, 1, 1.
13. Sorensen HT, Mellemkjær L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, Olsen JH (2000) Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. American Journal of Gastroenterology, 95, 2218-2224.
14. Derry S, Loke YK (2000) Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. British Medical Journal, 321, 1183-1187.
15. Silagy CA, McNeil JJ, Donnan GA, Tonkin AM, Worsam B, Campion K (1993) Adverse effects of low-dose aspirin in a healthy elderly population. Clinical Pharmacology and Therapeutics, 54, 84-89.
16. Prichard PJ, Kitchingman GK, Walt RP, Daneshmend TK, Hawkey CJ (1989) Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin. British Medical Journal, 298, 493-496.
17. Weil J, Colin-Jones D, Langman M et al. (1995) Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ, 310, 827-830.